This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (4)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Brian Vastag

JAMA. 2001;285:721-722.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Washington—At the end of a 3-day conference last month on the ethical, legal, and social repercussions of the genetic revolution, National Human Genome Research Institute director Francis Collins, MD, PhD, launched into cheerleader mode, urging the assembled researchers to design "truly exciting research agendas." He then rushed off to the White House for a final meeting with President Clinton and the latter's closest health advisors.

That Collins rated a place at the governmental head table is testament to the grandness of the genome project and all of its spin-offs, an enormous academic and industrial complex devoted to mining genomic ore for medical gold.

But as public awareness and the scientific successes of the genome project expand, the range of societal issues—genetic ownership rights, information privacy, and employment and insurance discrimination, to name just a few—are also expanding. Throw in challenges to notions of what it means to . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Problematic Variation in Local Institutional Review of a Multicenter Genetic Epidemiology Study
McWilliams et al.
JAMA 2003;290:360-366.
ABSTRACT | FULL TEXT  

Junking Science to Promote Tobacco
Yach and Bialous
AJPH 2001;91:1745-1748.
ABSTRACT | FULL TEXT